- A pure alloplastic (synthetic), non-ceramic resorbable bone graft particulate, the 200-300 crystal formulation features a specific Calcium-to-Phosphate ratio that chemically and crystallographically mimics human trabecular bone
Uses
- Large Defect Reconstruction:
- Ideal for traumatic, congenital, or surgical maxillofacial hard tissue defect repairs
- Sinus Floor Elevations:
- Used to pack the sub-antral cavity during sinus lifts to prepare for posterior dental implants
- Ridge Augmentation:
- Packed into major alveolar ridge deficiencies to expand structural bone volume prior to implant placement
- Periodontal Infrabony Defects:
- Packed into multi-walled periodontal pockets to regenerate lost alveolar bone around teeth
- Multi-Socket Preservation:
- Delivers high-volume particulate to fill extensive multi-rooted extraction sockets across a surgical quadrant
Features
- Non-Ceramic Crystal Clusters:
- Highly porous, hexagonal-shaped clusters bound to a single nucleus rather than a dense ceramic block
- Ultra-Hydrophilic Nature:
- Instantly draws in and absorbs medullary blood flow and cellular components upon contact
- Specific Ca:P Ratio:
- Mimics the physical and chemical properties of natural human bone to prevent a foreign body response
- Pure Formula:
- Free from alpha/beta tricalcium phosphates (\(\beta \)-TCP), amorphous phases, or pyro-phosphates that interfere with bone remodeling
Benefits
- Accelerated Angiogenesis:
- The 360-degree interlocking crystal lattice framework maximizes space for host cell infiltration and early blood vessel formation
- Controlled Resorption:
- Functions as an osteoconductive scaffold that slowly resorbs at a pace that perfectly aligns with host bone deposition
- Zero Washout with Proper Control:
- The highly hydrophilic clusters quickly form a stable, integrated clot with regional blood, lowering particulate migration when managed correctly
- Predictable Radiographic Tracking:
- Appears radiolucent on the day of surgery, allowing clinicians to cleanly observe the site, and transitions to radiopaque within 4 to 6 months as mineralized host bone matures
- Long Clinical Track Record:
- Provides clinicians with a safe, bio-compatible formulation backed by over 30 years of successful dental implant site development
